Argenta set to kick-off operations at its first US manufacturing facility

21 December, 2015 – Argenta, the New Zealand company dedicated to the development and manufacture of products for the health of animals, will commence operations at its new state-of-the-art manufacturing facility in Fort Dodge, Iowa, on 4 January, 2016.

Acquired in July 2015, the facility will be the third Argenta business operating out of the USA, but the company’s first US manufacturing site.

“The facility is world-class and the advanced manufacturing technologies we’ve acquired means the facility produces some of the most high-tech products available in animal health today,” says Doug Cleverly, Argenta managing director and co-founder.

“The Fort Dodge community has shown a great interest in what we are doing there and we are thrilled to have been so warmly welcomed to the area,” Cleverly adds.

Named AML Riverside, the 13,500 square metre facility is twice the size of Argenta’s South Auckland base and will complement its current New Zealand operations, as well as supporting its growth in the US.

Founded in South Auckland in 2006, Argenta currently has around 300 staff in New Zealand and the US, and exports animal health products and services to more than 40 countries. The engine behind Argenta’s growth and expansion is research and innovation: Since its beginning in 2006, the company has launched 45 new products for clients, some of which are now successful global brands.

The official opening of its AML Riverside will be celebrated at an event in Iowa on 4 January, attended by Cleverly, Argenta staff and Iowan VIPS. It will include a formal presentation and flag-raising ceremony.

For more information, contact:

Dr. Doug Cleverly

Managing Director and Founder

Phone: +64 9 250 3100

About Argenta

Argenta provides formulations research and development, analytical methods development, and pilot- and commercial scale manufacturing of animal health products. Founded in August 2006, Argenta is the leading provider of new product development and manufacturing services to the international animal health industry. In 2008, Argenta acquired New Jersey based clinical contract research provider, AlcheraBio, and in 2011 it opened a drug product research laboratory in Lawrence, Kansas City in 2011.